Patients with mild to moderate COPD plus elevated eosinophils risk a more rapid decline in lung function after exacerbations than those with lower eosinophil counts, researchers say.

But, in a prospective observational study published in Thorax, they have also found the decline can be mitigated if inhaled corticosteroids (ICS) are used as part of maintenance therapy.